Clinical Trial Update: GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of GPL in patients with relapsed/refractory diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• GPL

Snippet

Sponsor: Seoul National University Hospital | Conditions: Relapsed/refractory Diffuse Large B Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING